These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19578778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.
    Engel JB, Hahne JC, Häusler SF, Meyer S, Segerer SE, Diessner J, Dietl J, Honig A.
    Anticancer Res; 2012 May; 32(5):2063-8. PubMed ID: 22593489
    [Abstract] [Full Text] [Related]

  • 3. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB, Honig A, Schönhals T, Weidler C, Häusler S, Krockenberger M, Grunewald TG, Dombrowski Y, Rieger L, Dietl J, Wischhusen J.
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
    [Abstract] [Full Text] [Related]

  • 4. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [Abstract] [Full Text] [Related]

  • 5. PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer.
    Honig A, Hahne JC, Meyer S, Kranke P, Häusler S, Diessner J, Dietl J, Engel JB.
    Anticancer Res; 2012 May; 32(5):2035-41. PubMed ID: 22593485
    [Abstract] [Full Text] [Related]

  • 6. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L, Yano T, Osuga Y, Nakagawa S, Oishi H, Wada-Hiraike O, Tang X, Yano N, Kugu K, Schally AV, Taketani Y.
    Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
    [Abstract] [Full Text] [Related]

  • 13. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
    [Abstract] [Full Text] [Related]

  • 14. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J, Emons G, Pinski J, Schally AV.
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [Abstract] [Full Text] [Related]

  • 15. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
    Calabresi P, Goulette FA, Darnowski JW.
    Cancer Res; 2001 Sep 15; 61(18):6816-21. PubMed ID: 11559556
    [Abstract] [Full Text] [Related]

  • 16. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
    Iguchi T, Yachide-Noguchi T, Hashimoto Y, Nakazato S, Sagawa M, Ikeda Y, Kizaki M.
    Int J Mol Med; 2008 Feb 15; 21(2):163-8. PubMed ID: 18204782
    [Abstract] [Full Text] [Related]

  • 17. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Li H, Takai N, Yuge A, Furukawa Y, Tsuno A, Tsukamoto Y, Kong S, Moriyama M, Narahara H.
    Cancer Lett; 2010 Nov 28; 297(2):198-206. PubMed ID: 20547442
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.